Microfluidic Chip–Based Online Screening Coupled to Mass Spectrometry: Identification of Inhibitors of Thrombin and Factor Xa. (February 2016)

• Record Type: Journal Article
• Authors: Iyer, Janaki Krishnamoorthy; Otvos, Reka A.; Kool, Jeroen; Kini, R. Manjunatha
• Other Names: Wingfield Jonathan guest-editor.; Wilson Ian D. guest-editor.
• Is Part Of: Journal of biomolecular screening. Volume 21:Number 2(2016)
• Page Start: 212
• Page End: 220
• Publication Date: 2016-02
• Subjects: thrombosis -- benzamidine -- argatroban -- thrombin inhibitor -- FXa inhibitor; Drugs -- Analysis -- Periodicals; Drugs -- Testing -- Periodicals; Biomolecules -- Analysis -- Periodicals; 572.36
• DOI: 10.1177/1087057115602648
• Languages: English
• ISSNs: 1087-0571

Abstract

Thrombin and factor Xa (FXa) are critical enzymes of the blood coagulation cascade and are excellent targets of anticoagulant agents. Natural sources present an array of anticoagulants that can be developed as antithrombotic drugs. High-resolution, online screening techniques have been developed for the identification of drug leads from complex mixtures. In this study, we have developed and optimized a microfluidic online screening technique coupled to nano–liquid chromatography (LC) and in parallel with a mass spectrometer for the identification of thrombin and FXa inhibitors in mixtures. Inhibitors eluting from the nano-LC were split postcolumn in a 1:1 ratio; half was fed into a mass spectrometer (where its mass is detected), and the other half was fed into a microfluidic chip (which acts as a microreactor for the online assays). With our platform, thrombin and FXa inhibitors were detected in the assay in parallel with their mass identification. These methods are suitable for the identification of inhibitors from sample amounts as low as sub-microliter volumes.